agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
2.970
+0.080 (2.77%)
At close: May 12, 2025, 4:00 PM
2.960
-0.010 (-0.34%)
After-hours: May 12, 2025, 7:43 PM EDT
agilon health Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for agilon health stock have an average target of 4.56, with a low estimate of 2.00 and a high estimate of 9.00. The average target predicts an increase of 53.54% from the current stock price of 2.97.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 20 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 2 | 2 |
| Hold | 12 | 13 | 14 | 14 | 13 | 14 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $2 → $3 | Sell | Maintains | $2 → $3 | +1.01% | May 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.5 → $5 | Hold | Maintains | $2.5 → $5 | +68.35% | May 8, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 28, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $3.25 → $5 | Hold → Strong Buy | Upgrades | $3.25 → $5 | +68.35% | Apr 25, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $3.5 → $6 | Hold | Maintains | $3.5 → $6 | +102.02% | Apr 15, 2025 |
Financial Forecast
Revenue This Year
5.99B
from 6.06B
Decreased by -1.10%
Revenue Next Year
6.65B
from 5.99B
Increased by 10.96%
EPS This Year
-0.36
from -0.63
EPS Next Year
-0.22
from -0.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3B | 8.3B | 9.4B | ||
| Avg | 6.0B | 6.7B | 7.9B | ||
| Low | 5.7B | 5.9B | 6.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1% | 38.2% | 41.0% | ||
| Avg | -1.1% | 11.0% | 18.5% | ||
| Low | -5.4% | -1.6% | -3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.11 | -0.06 | 0.06 | |
| Avg | -0.36 | -0.22 | -0.12 | |
| Low | -0.46 | -0.31 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.